Diabetes and metabolism Archives - Page 3 of 4

Podcasts

Pumps and patches in management of diabetes

Patients wearing insulin pumps should be asked if they have a current emergency plan in case the pump breaks down, and fresh supplies of insulin pens

Podcasts

Multi comorbidity and polypharmacy from a T2D angle: Part 2

Your patient with T2DM has been diagnosed with exudative retinopathy. Dr Gary Deed and Dr Anita Sharma take a deeper dive into this common problem

Podcasts

Multi comorbidity and polypharmacy from a T2D angle: Part 1

We should have a high index of suspicion for diabetes complications in our patients with T2DM

Podcasts

Lifestyle modification and T2D

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

Podcasts

T2D and the heart

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

Podcasts

T2D and the foot

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

Podcasts

What’s in and what’s out in T2D management guidelines

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

Podcasts

A practical approach to first, second and third line treatment

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Podcasts

T2D and the kidney

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Podcasts

Non-insulin injectables for T2D

GLP1 agonists are a very important management option - GPs who have not yet used this class of medications should learn more and start

Podcasts

Indigenous diabetes

Genetic factors make lifestyle changes less effective and some are at risk of a form of malignant, rapidly progressive T2DM in the setting of severe insulin resistance

Monographs

SGLT2 and DPP4 Inhibition: An Ideal Combination

This article discusses the evidence for the combination use of SGLT2 inhibitors and DPP4 inhibitors, in addition to standard care, in the management of type 2 diabetes.

Diabetes and metabolism

Pumps and patches in management of diabetes

Patients wearing insulin pumps should be asked if they have a current emergency plan in case the pump breaks down, and fresh supplies of insulin pens

Multi comorbidity and polypharmacy from a T2D angle: Part 2

Your patient with T2DM has been diagnosed with exudative retinopathy. Dr Gary Deed and Dr Anita Sharma take a deeper dive into this common problem

Multi comorbidity and polypharmacy from a T2D angle: Part 1

We should have a high index of suspicion for diabetes complications in our patients with T2DM

Lifestyle modification and T2D

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

T2D and the heart

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

T2D and the foot

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

What’s in and what’s out in T2D management guidelines

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

A practical approach to first, second and third line treatment

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

T2D and the kidney

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Non-insulin injectables for T2D

GLP1 agonists are a very important management option - GPs who have not yet used this class of medications should learn more and start

Indigenous diabetes

Genetic factors make lifestyle changes less effective and some are at risk of a form of malignant, rapidly progressive T2DM in the setting of severe insulin resistance

SGLT2 and DPP4 Inhibition: An Ideal Combination

This article discusses the evidence for the combination use of SGLT2 inhibitors and DPP4 inhibitors, in addition to standard care, in the management of type 2 diabetes.

Get the app

Site

Company

Connect

Legal

Healthed

Diabetes and metabolism

Patients wearing insulin pumps should be asked if they have a current emergency plan in case the pump breaks down, and fresh supplies of insulin pens

Your patient with T2DM has been diagnosed with exudative retinopathy. Dr Gary Deed and Dr Anita Sharma take a deeper dive into this common problem

We should have a high index of suspicion for diabetes complications in our patients with T2DM

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

GLP1 agonists are a very important management option - GPs who have not yet used this class of medications should learn more and start

Genetic factors make lifestyle changes less effective and some are at risk of a form of malignant, rapidly progressive T2DM in the setting of severe insulin resistance

This article discusses the evidence for the combination use of SGLT2 inhibitors and DPP4 inhibitors, in addition to standard care, in the management of type 2 diabetes.

Get the app

Site

Company

Connect

Legal

Extra Details

Healthed